🇺🇸 FDA

Intelligence Platform

Patents

Browse 94 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12351609

Use of a small native peptide activator of SERCA pump for treatment of heart failure and o

The Board of Regents of the University of Texas System · Granted Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12257224

Methods of administration for highly water-soluble salts of a short acting phenylalkylamin

Milestone Pharmaceuticals Inc. · Granted Tue Mar 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12202832

Heterocyclic compounds having a calcium-sensing receptor antagonistic activity

Takeda Pharmaceutical Company Limited · Granted Tue Jan 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12077502

Formulations of T-type calcium channel modulators and methods of use thereof

PRAXIS PRECISION MEDICINES, INC. · Granted Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11773138

Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof

Theradaptive, Inc. · Granted Tue Oct 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11649207

Formulations of T-type calcium channel modulators and methods of use thereof

PRAXIS PRECISION MEDICINES, INC. · Granted Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11427540

Formulations of T-type calcium channel modulators and methods of use thereof

PRAXIS PRECISION MEDICINES, INC. · Granted Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11358947

Substituted 2-acylamino-cycloalkylthiophene-3-carboxylic acid arylamides as inhibitors of

The Regents of the University of California · Granted Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11192923

Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof

Theradaptive, Inc. · Granted Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11111278

Use of a small native peptide activator of SERCA pump for treatment of heart failure and o

The Board of Regents of the University of Texas System · Granted Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11103528

Slow release calcium composition

United States of America as represented by the Secretary of the Air Force · Granted Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10766908

Calcium L-lactate frameworks as naturally degradable carriers

The Regents of the University of California · Granted Tue Sep 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10675246

Orally administrable compositions comprising calcium

CEROLIFE LLC · Granted Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10617136

Calcium oxide compound with high purity

ARKIM KIMYEVI MADDELER SANAYI VE TICARET ANONIM SIRKETI · Granted Tue Apr 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10570183

Use of a small native peptide activator of SERCA pump for treatment of heart failure and o

The Board of Regents of the University of Texas System · Granted Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10357460

Particulate comprising a calcium-containing compound and a sugar alcohol

TAKEDA AS · Granted Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10258576

Particulate comprising a calcium-containing compound and a sugar alcohol

TAKEDA AS · Granted Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10117848

Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and

Milestone Pharmaceuticals Inc. · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10105366

Selective calcium channel antagonists

Northwestern University · Granted Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10092593

Citrate-rich calcium-magnesium supplement and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Oct 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10058587

Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity

Soricimed Biopharma Inc. · Granted Tue Aug 28 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10010522

Short acting phenylalkylamine calcium channel blockers and uses thereof

Milestone Pharmaceuticals Inc. · Granted Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10010523

Short acting phenylalkylamine calcium channel blockers and uses thereof

Milestone Pharmaceuticals Inc. · Granted Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10010524

Short acting phenylalkylamine calcium channel blockers and uses thereof

Milestone Pharmaceuticals Inc. · Granted Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted